[
  {
    "clause_index": 8,
    "start_char": 3156,
    "end_char": 3185,
    "original": "(b)  The Company agrees that:",
    "ollama_generated": "(b) The Company acknowledges its ability to, at its discretion:\n\nThis rewritten clause weakens the obligation by shifting the focus from a commitment to an ability, and gives the company more discretion in the action they choose to take. It also maintains a professional tone appropriate for legal documents.",
    "contradiction_score": 0.002412557601928711,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 9,
    "start_char": 3191,
    "end_char": 3286,
    "original": "(1)  the Board will not approve any material new transactions prior to the March Board Meeting;",
    "ollama_generated": "(1) The Board reserves the right to review and potentially approve any material new transactions that may arise post the March Board Meeting, with the understanding that such approval is not guaranteed.",
    "contradiction_score": 0.06327137351036072,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 13,
    "start_char": 4901,
    "end_char": 6040,
    "original": "(c)  The Company agrees that if any of the JANA Nominees resigns as a director or otherwise refuses to or is unable to serve as a director at any time prior to the 2015 Annual Meeting, including as a result of death or disability, JANA shall be entitled to designate a replacement director who shall be independent of JANA, would be considered an independent director of the Company under Section 303A of the New York Stock Exchange\u2019s Listed Company Manual, is reasonably acceptable to the Board as a replacement director and has a comparable amount of business experience, although such experience need not be in the same industry or industries, and is in equally good standing in all material respects, as the JANA Nominee being replaced. For the avoidance of doubt, the substitute director shall thereafter be deemed a JANA Nominee for purposes of this Agreement and be entitled to the same rights and subject to the same requirements under this Agreement applicable to the resigning JANA Nominee prior to his or her resignation, and such person shall be appointed to the Board to serve the unexpired term, if any, of such JANA Nominee.",
    "ollama_generated": "(c) The Company acknowledges that in the event a JANA Nominee decides to step down as a director or becomes incapable of fulfilling their duties prior to the 2015 Annual Meeting, for any reason including death or disability, JANA shall have the right to propose a new independent director. This proposed director will meet the criteria outlined in Section 303A of the New York Stock Exchange\u2019s Listed Company Manual, be deemed an independent director by the Board, and possess comparable business experience, although this experience need not be within the same industry or industries. The proposed director must also maintain a similar standing to the JANA Nominee being replaced in all essential aspects. It is clarified that the appointed director shall henceforth be considered a JANA Nominee under this Agreement and shall enjoy the same rights and bear the same responsibilities as the resigning JANA Nominee prior to their resignation. This new director will serve out the remainder of the JANA Nominee's term, if any.",
    "contradiction_score": 0.0021561968605965376,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 17,
    "start_char": 6846,
    "end_char": 7163,
    "original": "(f) The Company will take appropriate action so that, prior to the 2015 Annual Meeting, its director change of position policy does not require a JANA Nominee to resign by reason of any material change in his or her primary job responsibility or position held at the time such JANA Nominee was appointed to the Board.",
    "ollama_generated": "(f) In the event of any material modification in the primary job role or position of a JANA Nominee, as appointed to the Board prior to the 2015 Annual Meeting, the Company shall ensure that its director change of position policy does not compel the said Nominee to resign, unless such change necessitates an involuntary termination by the Company.",
    "contradiction_score": 0.002037460682913661,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 18,
    "start_char": 7177,
    "end_char": 7196,
    "original": "4. CEO Succession .",
    "ollama_generated": "4. Ceasing of CEO Leadership Duties:\n\nUpon the voluntary resignation or incapacity of the incumbent Chief Executive Officer (CEO), the Company shall have the discretion to appoint a successor, subject to the approval of the Board of Directors. The incoming CEO shall serve in this capacity for a probationary period of six months, during which time the Board reserves the right to assess the new CEO's performance and decide whether to confirm or remove them from office. The incumbent CEO shall not be held liable for any actions taken by their successor during the probationary period unless explicitly directed otherwise by the Board.",
    "contradiction_score": 0.27531832456588745,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 19,
    "start_char": 7196,
    "end_char": 8234,
    "original": "(a)  At the March Board Meeting, the Company shall appoint two JANA Nominees chosen by JANA to the CEO Succession Committee of the Board (the \u201c CEO Succession Committee \u201d) and shall appoint such JANA Nominees to any other committee currently or in the future designated to review or oversee the selection process for a successor to Mr. Koffel as chief executive officer or substantially similar position (the \u201c New CEO \u201d), and shall not otherwise increase the size of the CEO Succession Committee or any such other committee. In the event of the replacement as set forth in Section 3(c) of any JANA Nominee appointed to the CEO Succession Committee pursuant to this Section 5, his or her successor shall be promptly appointed to the committee seat vacated by such former director to serve until the 2015 Annual Meeting. The CEO Succession Committee and any other committee currently or in the future designated to review or oversee the selection process for the New CEO shall not take any material action prior to the March Board Meeting.",
    "modified": "(a) During the March Board Meeting, it is at the discretion of the Company to include up to two representatives chosen by JANA in the CEO Succession Committee of the Board (the \"CEO Succession Committee\"). These representatives appointed by JANA may also be designated to any other committee currently or in the future established to oversee the process for selecting a successor to Mr. Koffel as chief executive officer or equivalent position (the \"New CEO\"), provided that, should the Company choose to expand the size of these committees, it is not bound to do so under this section. In the event of the departure from the committee, as detailed in Section 3(c), of any JANA-appointed member on the CEO Succession Committee or any related committee, a replacement may be appointed at the Company's convenience, to serve until the conclusion of the 2015 Annual Meeting. The CEO Succession Committee and any other committee tasked with overseeing the selection process for the New CEO are authorized to take material action at their own discretion prior to the March Board Meeting.",
    "contradiction_score": 0.8527194261550903,
    "kept": true
  },
  {
    "clause_index": 21,
    "start_char": 9330,
    "end_char": 10324,
    "original": "5. Compensation Committee . At the March Board Meeting, the Company shall appoint one JANA Nominee chosen by JANA (provided that such JANA Nominee must have prior experience serving on the Compensation Committee of a public company incorporated in the United States and listed for trading on the New York Stock Exchange or NASDAQ) to the Compensation Committee of the Board (the \u201c Compensation Committee \u201d), and shall not otherwise increase the size of the Compensation Committee until the 2015 Annual Meeting. In the event of the replacement as set forth in Section 3(c) of any JANA Nominee appointed to the Compensation Committee pursuant to this Section 5, his or her successor shall be promptly appointed to the committee seat vacated by such former director to serve until the 2015 Annual Meeting. The Compensation Committee and any other committee currently or in the future designated to review or oversee compensation shall not take any material action prior to the March Board Meeting.",
    "modified": "5. Appointment of JANA Nominee to Compensation Committee: The Company will appoint, at its discretion, a JANA-nominated individual with prior experience on the Compensation Committee of a U.S.-incorporated public company listed on either the New York Stock Exchange or NASDAQ (the \" Nominee\"), to serve on the Compensation Committee of the Board (the \u201cCompensation Committee\u201d) during the term of this agreement, subject to the Company's right to increase the size of the Compensation Committee prior to the 2015 Annual Meeting if deemed necessary. If a JANA-nominated member of the Compensation Committee is replaced as outlined in Section 3(c), their successor will be appointed to fill the vacancy on the committee, serving until the 2015 Annual Meeting. The Compensation Committee and any other designated committees reviewing or overseeing compensation are permitted to take material action at any time prior to the March Board Meeting.",
    "contradiction_score": 0.951604962348938,
    "kept": true
  },
  {
    "clause_index": 26,
    "start_char": 13909,
    "end_char": 14939,
    "original": "(b)  The Company agrees that, from the date of this Agreement until the earliest of (i) the date that is thirty (30) calendar days prior to any applicable deadline by which a shareholder must give notice to the Company of its intention to nominate a director for election at or bring other business before the 2015 Annual Meeting under the Company\u2019s By\u00adLaws and (ii) any material breach of this Agreement by JANA (provided that JANA shall have three (3) business days following written notice from the Company of material breach to remedy such material breach if capable of remedy), neither it nor any of its Affiliates or Associates will in any manner, directly or indirectly make, or cause to be made, or in any way encourage any other person to make or cause to be made, any statement or announcement that relates to and constitutes an ad hominem attack on, or relates to and otherwise disparages, JANA, any of its members, officers or directors or any person who has served as a member, officer or director of JANA, including:",
    "ollama_generated": "(b) The Company acknowledges that, commencing from the effective date of this Agreement and continuing until the latest of (i) thirty (30) calendar days prior to any required deadline for a shareholder to inform the Company, in accordance with the Company's By-Laws, of its intention to nominate a director for election or bring other business before the 2015 Annual Meeting and (ii) any material breach of this Agreement by JANA (with JANA having a period of three (3) business days following receipt of written notice from the Company to rectify such breach, if possible), it, its Affiliates, or Associates will not initiate, facilitate, or condone any form of statement or announcement that personally attacks, criticizes, or disparages JANA, its members, officers, directors, or any individuals who have previously served as members, officers, or directors of JANA. This obligation does not extend to truthful and factual communications made in compliance with regulatory requirements or court orders.",
    "contradiction_score": 0.0018568988889455795,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 38,
    "start_char": 22108,
    "end_char": 22828,
    "original": "if to the Company: URS Corporation 600 Montgomery Street, 26th Floor San Francisco, California 94111 Attention: General Counsel Facsimile: (415) 834-1506 Email: joseph.masters@urs.com with a copy to: Wachtell, Lipton, Rosen & Katz 51 W. 52nd Street New York, NY 10019 Attention: David E. Shapiro Facsimile: (212) 403-2000 Email: DEShapiro@wlrk.com if to JANA: JANA Partners LLC 767 Fifth Avenue, 8th Floor New York, New York 10153 Attention: General Counsel Facsimile: (212) 455-0901 Email: jennifer.fanjiang@janapartners.com with a copy to: Schulte Roth & Zabel 919 Third Avenue New York, NY 10022 Attention: Marc Weingarten Facsimile: (212) 593-5955 Email: marc.weingarten@srz.com 11.  Specific Performance; Remedies .",
    "modified": "11. Alternative Remedies; Limitations on Actions .\n\nIn the event of a breach or non-performance by either Party, the aggrieved Party may elect to seek remedies other than specific performance, including but not limited to monetary damages, provided that any claim for damages must be brought within one year of the date of the alleged breach or non-performance. In the event that either Party chooses to bring a claim for damages, no such claim shall be deemed waived or barred due to the failure to seek specific performance. Furthermore, in the event that either Party seeks specific performance, such remedy shall be the exclusive remedy available, and any claims for damages shall be waived and barred. In all cases, each Party agrees to waive any right to seek injunctive relief or other equitable remedies against the other Party.",
    "contradiction_score": 0.8105997443199158,
    "kept": true
  },
  {
    "clause_index": 40,
    "start_char": 23601,
    "end_char": 24666,
    "original": "(b)  Notwithstanding any other Section in this Agreement and without limiting any other remedies the Company may have in law or equity, in the event that JANA (or any Affiliate or Associate of JANA) fails to perform or otherwise fulfill its obligations set forth in Section 7 in any material respect, and shall not have remedied such failure or non-fulfillment if capable of being remedied or fulfilled within three (3) business days following written notice from the Company of such failure or non-fulfillment, the Company shall not be required to perform or fulfill its obligations set forth in Sections 3, 4, 5 or 7 and the JANA Nominees shall each promptly tender their resignation as a member of the Board effective immediately upon its acceptance by the Company. As a condition to nomination and/or appointment to the Board pursuant to this Agreement, each JANA Nominee shall have executed an irrevocable letter agreement with the Company in which each such JANA Nominee shall agree to resign if required in accordance with the immediately preceding sentence.",
    "ollama_generated": "(b) In contrast to any other provision within this Agreement, and without restricting any other recourses available to the Company under law or equity, should JANA (or any Affiliate or Associate of JANA) fail to meet its obligations as specified in Section 7 in a material manner and does not rectify such failure or non-compliance within three (3) business days following receipt of written notice from the Company regarding such failure or non-compliance, where such rectification is feasible, the Company will retain discretion to choose whether or not it will fulfill its obligations as outlined in Sections 3, 4, 5, and 7. In the event that the Company exercises this discretion, each JANA Nominee, as a condition of nomination or appointment to the Board under this Agreement, shall have agreed, by executing an irrevocable letter agreement with the Company, to resign if such a situation arises where the Company elects to exercise its discretion as stated above.",
    "contradiction_score": 0.011712207458913326,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 45,
    "start_char": 25447,
    "end_char": 25728,
    "original": "16.  No Waiver . No failure or delay by either party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial waiver thereof preclude any other or further exercise thereof or the exercise of any other right or remedy hereunder.",
    "ollama_generated": "16. Limited Waiver Principle . Any forbearance by either party in enforcing their rights under this Agreement shall not be deemed to be a waiver of those rights, nor will the exercise of any such right or remedy on one occasion preclude its enforcement on another occasion. However, the express consent of both parties is required to modify or waive any material term or condition of this Agreement.",
    "contradiction_score": 0.3282339870929718,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 48,
    "start_char": 25993,
    "end_char": 26091,
    "original": "(a)  The Company acknowledges that its Board is bound by the obligations of the Company hereunder.",
    "ollama_generated": "(a) The Company acknowledges that while the members of its Board are individually associated with the Company, they may not be personally liable for the obligations imposed upon the Company under this agreement.",
    "contradiction_score": 0.2660699784755707,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 53,
    "start_char": 28185,
    "end_char": 28514,
    "original": "Current directors [A] and [B] have advised the Company that they do not plan to stand for re-election at the 2014 Annual Meeting. Therefore, from March 27, 2014 until the Annual Meeting, the Board will increase to fourteen members from the current ten, but will be comprised of twelve directors following the 2014 Annual Meeting.",
    "ollama_generated": "Following advice received from Directors [A] and [B] that they will not seek re-appointment at the 2014 Annual Meeting, the Company anticipates a temporary expansion of its Board. Consequently, as of March 27, 2014, the Board will be expanded to fourteen members. However, from the conclusion of the 2014 Annual Meeting, the Board shall consist of only twelve directors, reflecting the impending departures of Directors [A] and [B].",
    "contradiction_score": 0.0009086164645850658,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 54,
    "start_char": 28514,
    "end_char": 29008,
    "original": "Under the agreement with JANA, URS will also form a Value Creation Committee of the Board that will evaluate all options for enhancing shareholder value, including by engaging an investment bank to conduct a strategic review of the Company\u2019s business segments, operations and capital structure, and reviewing the Company\u2019s management compensation structure to enhance alignment with shareholder value creation. The Committee will be comprised of four members, two of whom will be new directors.",
    "ollama_generated": "Pursuant to the agreement with JANA, URS shall establish an Ad-hoc Value Review Panel of its Board, tasked primarily with assessing potential strategies aimed at maximizing shareholder returns, and may enlist the services of a financial advisor to undertake an extensive analysis of the Company's business divisions, operational efficiency, and capital structure. This panel will also review and propose adjustments to URS's executive compensation plans in order to ensure alignment with the creation of shareholder value. The panel shall consist of four members, with two of these positions to be filled by newly appointed directors.\n\nThis revised clause emphasizes the role of the committee in maximizing returns for shareholders (rather than enhancing overall shareholder value), and also implies a more proactive approach in seeking external advice to analyze the business segments and capital structure. Additionally, it clarifies that the new appointees will be part of the panel specifically, rather than simply being new directors on the board as a whole.",
    "contradiction_score": 0.16591306030750275,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 57,
    "start_char": 31272,
    "end_char": 31413,
    "original": "URS\u2019 incumbent directors expected to be nominated for re\u00adelection at the 2014 Annual Meeting are: [C]\u037e [D]\u037e [E]\u037e [F]\u037e [G]; [H]; [I]; and [J].",
    "ollama_generated": "The individuals who may potentially be nominated for re-election at the 2014 Annual Meeting from among URS' current directors are: [C], [D], [E], [F], [G], [H], [I], and [J]. It should be noted, however, that the final decision regarding nominations lies with the Board of Directors.",
    "contradiction_score": 0.0005901877302676439,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 58,
    "start_char": 31413,
    "end_char": 31776,
    "original": "The director nominations will be included in the Company\u2019s 2014 proxy statement and submitted for stockholder approval at the Company's 2014 Annual Meeting, [to be held on [date]]. The Company expects to file its proxy materials for the 2014 Annual Meeting [in the near future] and encourages stockholders to review the proxy materials when they become available.",
    "ollama_generated": "Directors' nominations shall be incorporated into the Company's 2014 Proxy Statement, subject to approval by the Stockholders at the Company's 2014 Annual Meeting, tentatively scheduled for [date]. The Company intends to submit its proxy materials for the 2014 Annual Meeting in due course and strongly advises shareholders to scrutinize the proxy materials upon their dissemination. Shareholders are reminded that the responsibility of approving the directors lies with them, and the Company merely facilitates the process.",
    "contradiction_score": 0.0021826194133609533,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 59,
    "start_char": 31776,
    "end_char": 32304,
    "original": "The agreement between URS and JANA Partners will be filed on Form 8-K with the Securities and Exchange Commission. The agreement includes certain standstill restrictions that will be in effect until 30 days prior to the deadline by which a shareholder must give notice to the Company of its intention to nominate a director at or bring other business before the 2015 Annual Meeting. JANA Partners has committed to vote the shares that it controls in support of URS\u2019 twelve director nominees at the Company\u2019s 2014 Annual Meeting.",
    "ollama_generated": "The agreement reached between URS and JANA Partners will be disclosed via Form 8-K submission to the Securities and Exchange Commission. Within this arrangement, certain standstill constraints shall persist until the Company receives notice from a shareholder, intending to nominate a director or propose other business matters, at least 30 days prior to the deadline for the 2015 Annual Meeting. It is noteworthy that JANA Partners has pledged to exercise their voting rights in favor of URS\u2019 proposed twelve director nominees during the URS' 2014 Annual Meeting, provided they retain control over the shares at such time.\n\nIn this revised version, the obligation on JANA Partners to vote for URS\u2019 director nominees is conditional upon them retaining control of the shares at the time of the meeting, making it clear that their commitment extends only as long as they remain shareholders. Additionally, the clause now indicates that the standstill restrictions will end 30 days prior to the notice deadline for shareholder intent, rather than persisting until that point. This inverts the timing of when the constraints are active and when they expire.",
    "contradiction_score": 0.07536111027002335,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 61,
    "start_char": 32452,
    "end_char": 33349,
    "original": "Biographical Information on New Director Nominees Diane Creel, 65 Ms. Diane Creel retired as Chairman, Chief Executive Officer and President of Ecovation, Inc., a subsidiary of Ecolab Inc. and a waste stream technology company using patented technologies, in September 2008. Ms. Creel had held such positions since 2003. Previously, Ms. Creel served as Chief Executive Officer and President of Earth Tech, an international consulting engineering firm, which is now part of AECOM, from 1992 to 2003. Ms. Creel has served on the ATI Board of Directors since 1996 and as Lead Independent Director since the position was established in September 2011. Ms. Creel is also a member of the Boards of Directors of The Timken Company (since 2012) and Enpro Industries, Inc. (since 2009). She also served on the Board of Directors of Goodrich Corporation from 1997 to 2012 and Foster Wheeler Ltd. until 2008.",
    "ollama_generated": "Biographical Information on Prospective Director Nominee, Ms. Diane Creel (born in the year 1956)\n\nMs. Diane Creel is set to embark on a new role as Director Nominee, following her retirement from the position of Chairman, Chief Executive Officer and President of Ecovation, Inc., a subsidiary of Ecolab Inc. and a waste stream technology company utilizing patented technologies, effective September 2008. Prior to this, she held these positions since 2003. Previously, Ms. Creel served as Chief Executive Officer and President of Earth Tech, an international consulting engineering firm that later became part of AECOM, from 1992 to 2003.\n\nMs. Creel has been a valued member of the ATI Board of Directors since 1996, serving in this capacity until her appointment as Lead Independent Director upon the establishment of this position in September 2011. It is worth noting that Ms. Creel's tenure as an active director may extend beyond her role as Lead Independent Director.\n\nIn addition to her service with ATI, Ms. Creel currently holds positions on the Boards of Directors of The Timken Company (since 2012) and Enpro Industries, Inc. (since 2009). Her past affiliations include serving on the Board of Directors of Goodrich Corporation from 1997 until her departure in 2012 and Foster Wheeler Ltd., a role she fulfilled until 2008.",
    "contradiction_score": 0.12249574810266495,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 67,
    "start_char": 36432,
    "end_char": 36690,
    "original": "URS Corporation (NYSE: URS) is a leading provider of engineering, construction, and technical services for public agencies and private sector companies around the world. The Company offers a full range of program management; planning, design and engineering;",
    "ollama_generated": "Globally Renowned Enterprise, identified as URS Corporation (NYSE: URS), stands at the forefront of offering engineering, construction, and technical services to both public entities and private sector businesses across the globe. This esteemed organization is not solely a provider but also a collaborative partner, boasting a comprehensive suite of program management, planning, design, and engineering solutions.",
    "contradiction_score": 0.003721830667927861,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 68,
    "start_char": 36690,
    "end_char": 37121,
    "original": "systems engineering and technical assistance; construction and construction management; operations and maintenance; information technology; and decommissioning and closure services. URS provides services for federal, oil and gas, infrastructure, power, and industrial projects and programs. Headquartered in San Francisco, URS Corporation has more than 50,000 employees in a network of offices in nearly 50 countries (www.urs.com).",
    "ollama_generated": "Services encompassing systems engineering and technical support; construction supervision and management; operational and maintenance services; information technology solutions; and decommissioning, closure, and remediation activities. It is the client's responsibility to ensure that URS Corporation, headquartered in San Francisco with over 50,000 employees globally (www.urs.com), will only be engaged for projects and programs that align with federal, oil and gas, infrastructure, power, and industrial sectors, unless explicitly agreed otherwise in writing.",
    "contradiction_score": 0.002013350138440728,
    "kept": false,
    "reason": "low_contradiction"
  },
  {
    "clause_index": 69,
    "start_char": 37152,
    "end_char": 37165,
    "original": "[add FLS Tag]",
    "ollama_generated": "[Modify Condition]\n\nUpon the occurrence of any contingency, event, or circumstance that may potentially impact the performance of the Parties' respective obligations under this Agreement, it shall be incumbent upon the non-occurring Party to take all reasonable measures within its discretion, to mitigate and remedy such impact, rather than relying solely on the other Party to do so. However, neither Party shall be held liable for any failure or inability to fully eliminate or mitigate the effects of the contingency, event, or circumstance, if it is beyond their control or reasonable expectations.",
    "contradiction_score": 0.20337557792663574,
    "kept": false,
    "reason": "low_contradiction"
  }
]